Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression.
Rubenich DS, de Souza PO, Omizzollo N, Aubin MR, Basso PJ, Silva LM, da Silva EM, Teixeira FC, Gentil GFS, Domagalski JL, Cunha MT, Gadelha KA, Diel LF, Gelsleichter NE, Rubenich AS, Lenz GS, de Abreu AM, Kroeff GM, Paz AH, Visioli F, Lamers ML, Wink MR, Worm PV, Araújo AB, Sévigny J, Câmara NOS, Ludwig N, Braganhol E. Rubenich DS, et al. Among authors: gelsleichter ne. Front Immunol. 2023 May 24;14:1183465. doi: 10.3389/fimmu.2023.1183465. eCollection 2023. Front Immunol. 2023. PMID: 37292196 Free PMC article.
Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis.
Gelsleichter NE, de Souza PO, Teixeira FC, Debom GN, Lenz GS, Roliano GG, de Cássia Sant'ana R, Visioli F, Fachel FNS, Michels LR, Azambuja JH, Teixeira HF, Braganhol E. Gelsleichter NE, et al. Cell Mol Neurobiol. 2023 Aug;43(6):2939-2951. doi: 10.1007/s10571-023-01338-4. Epub 2023 Apr 13. Cell Mol Neurobiol. 2023. PMID: 37055607
ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use.
Leite RO, de Souza PO, Haas CB, da Silveira F, Mohr KR, Bertoni APS, Soares MS, Azambuja JH, Prá MD, da Cruz LLP, Gelsleichter NE, Begnini K, Hasko G, Wink MR, Spanevello RM, Braganhol E. Leite RO, et al. Among authors: gelsleichter ne. Clin Exp Med. 2023 Nov;23(7):3651-3662. doi: 10.1007/s10238-023-01045-w. Epub 2023 Mar 21. Clin Exp Med. 2023. PMID: 36943594 Free PMC article.
Design and synthesis of new adamantyl derivatives as promising antiproliferative agents.
Shahin AI, Zaraei SO, AlKubaisi BO, Ullah S, Anbar HS, El-Gamal R, Menon V, Abdel-Maksoud MS, Oh CH, El-Awady R, Gelsleichter NE, Pelletier J, Sévigny J, Iqbal J, Al-Tel TH, El-Gamal MI. Shahin AI, et al. Among authors: gelsleichter ne. Eur J Med Chem. 2023 Jan 15;246:114958. doi: 10.1016/j.ejmech.2022.114958. Epub 2022 Nov 26. Eur J Med Chem. 2023. PMID: 36470105
Achyrocline satureioides (Lam.) DC (Asteraceae) Extract-Loaded Nanoemulsions as a Promising Topical Wound Healing Delivery System: In Vitro Assessments in Human Keratinocytes (HaCaT) and HET-CAM Irritant Potential.
Balestrin LA, Kreutz T, Fachel FNS, Bidone J, Gelsleichter NE, Koester LS, Bassani VL, Braganhol E, Dora CL, Teixeira HF. Balestrin LA, et al. Among authors: gelsleichter ne. Pharmaceutics. 2021 Aug 12;13(8):1241. doi: 10.3390/pharmaceutics13081241. Pharmaceutics. 2021. PMID: 34452202 Free PMC article.
Chitosan-coated rosmarinic acid nanoemulsion nasal administration protects against LPS-induced memory deficit, neuroinflammation, and oxidative stress in Wistar rats.
Fachel FNS, Michels LR, Azambuja JH, Lenz GS, Gelsleichter NE, Endres M, Scholl JN, Schuh RS, Barschak AG, Figueiró F, Bassani VL, Henriques AT, Koester LS, Teixeira HF, Braganhol E. Fachel FNS, et al. Among authors: gelsleichter ne. Neurochem Int. 2020 Dec;141:104875. doi: 10.1016/j.neuint.2020.104875. Epub 2020 Oct 8. Neurochem Int. 2020. PMID: 33039443 Free article.
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model.
Azambuja JH, Schuh RS, Michels LR, Gelsleichter NE, Beckenkamp LR, Lenz GS, de Oliveira FH, Wink MR, Stefani MA, Battastini AMO, Teixeira HF, Braganhol E. Azambuja JH, et al. Among authors: gelsleichter ne. Cancer Chemother Pharmacol. 2020 Jun;85(6):1177-1182. doi: 10.1007/s00280-020-04077-1. Epub 2020 May 16. Cancer Chemother Pharmacol. 2020. PMID: 32417936
Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme.
Bona NP, Pedra NS, Azambuja JH, Soares MSP, Spohr L, Gelsleichter NE, de M Meine B, Sekine FG, Mendonça LT, de Oliveira FH, Braganhol E, Spanevello RM, da Silveira EF, Stefanello FM. Bona NP, et al. Among authors: gelsleichter ne. Metab Brain Dis. 2020 Feb;35(2):283-293. doi: 10.1007/s11011-019-00519-9. Epub 2019 Nov 26. Metab Brain Dis. 2020. PMID: 31773434
14 results